Metrion Biosciences was formed in September 2015, following a management buyout of Xention Limited’s contract research business. The Metrion team has substantial experience of providing high quality drug discovery services for ion channel targets to clients on a fee-for-service or collaboration basis. Metrion is also a leading provider of cardiac safety profiling, cardiac translational assays and neuronal translational assays.
Our state of the art laboratory facility is located at Granta Park, the largest research park in Cambridge (UK), and the Metrion team takes pride in providing a knowledgeable, collaborative and flexible service to our clients.
Contact us if you would like further information about our general capabilities or have a specific enquiry.